On October 8, Caldera Medical announced the acquisition of UVision 360, Inc., the developer of the LUMINELLE® hysteroscopy and cystoscopy systems. Financial terms of the deal were not disclosed.
UVision 360 designs and develops innovative, minimally invasive hysteroscopy and cystoscopy systems that enhance precision and patient outcomes in gynecologic procedures. The company’s LUMINELLE® system offers visualization and a simplified workflow, helping physicians in clinical and surgical settings.
Headquartered in Westlake, California, Caldera Medical is a privately held women’s health medical device company focused on minimally invasive applications.
The acquisition of UVision 360 bolsters Caldera Medical’s minimally invasive solutions, particularly in the realm of advanced hysteroscopy, broadening its portfolio for the diagnosis and treatment of conditions such as polyps, fibroids and intrauterine pathology.
“We are excited to integrate LUMINELLE’s technology into Caldera Medical’s growing portfolio,” said Bryon Merade, CEO of Caldera Medical. “This acquisition strengthens our commitment to offering gynecologic surgeons state-of-the-art tools that streamline hysteroscopic procedures while enhancing patient safety and clinical outcomes.”
According to data captured in the LevinPro HC database, this acquisition marks the 71st Medical Device transaction of 2024. There were 113 Medical Device deals announced during 2023, and 124 announced during 2022.
